Unknown

Dataset Information

0

Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.


ABSTRACT: Epothilones are relatively new tubulin-poison anticancer drugs. Iso-fludelone (KOS-1803) is a synthetic third generation epothilone drug discovered at Memorial Sloan Kettering Cancer Center, and currently in phase I clinical trials. We report an LC-MS/MS assay for the sensitive, accurate and precise quantitation of iso-fludelone in 0.2mL of human plasma. Validation was performed according to FDA guidance. The assay comprised of KOS-1724 as the internal standard and an MTBE liquid-liquid extraction with a water wash step. Separation was achieved with an YMC-Pack ODS-AQ column and an isocratic mobile phase of 0.1% formic acid in acetonitrile and water (70:30, v/v) at 0.3mL/min for 4min. Chromatographic separation was followed by electrospray, positive-mode ionization tandem mass spectrometric detection in the multiple reaction monitoring (MRM) mode. The assay was linear from 0.1 to 300ng/mL and was accurate (-9.41 to -7.07%) and precise (1.03-13.7%) which fulfilled FDA criteria for validation. Recovery from plasma was 73.9-79.7% and ion suppression was negligible (-22.8 to -31.3%). Plasma freeze-thaw stability (99.97-105.7%), stability for 11 months at -80°C (94.93-107.9%), and stability for 6h at room temperature (94.75-105.5%) were all acceptable. This assay is currently being applied to quantitate iso-fludelone in clinical samples.

SUBMITTER: Christner SM 

PROVIDER: S-EPMC4179924 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.

Christner Susan M SM   Parise Robert A RA   Levine Erica D ED   Rizvi Naiyer A NA   Gounder Mrinal M MM   Beumer Jan H JH  

Journal of pharmaceutical and biomedical analysis 20140812


Epothilones are relatively new tubulin-poison anticancer drugs. Iso-fludelone (KOS-1803) is a synthetic third generation epothilone drug discovered at Memorial Sloan Kettering Cancer Center, and currently in phase I clinical trials. We report an LC-MS/MS assay for the sensitive, accurate and precise quantitation of iso-fludelone in 0.2mL of human plasma. Validation was performed according to FDA guidance. The assay comprised of KOS-1724 as the internal standard and an MTBE liquid-liquid extracti  ...[more]

Similar Datasets

| S-EPMC7064611 | biostudies-literature
| S-EPMC5790688 | biostudies-literature
| S-EPMC5439074 | biostudies-literature
| S-EPMC4110960 | biostudies-literature
| S-EPMC3830928 | biostudies-literature
| S-EPMC3767123 | biostudies-literature
| S-EPMC5196007 | biostudies-literature
| S-EPMC5814678 | biostudies-literature
| S-EPMC4188709 | biostudies-literature
| S-EPMC6190535 | biostudies-literature